title: Glucagon-like peptide-1 receptor agonists and risk of breast cancer.
authors: Division of General Internal Medicine, Department of Medicine, MetroHealth System/Case Western Reserve University, Cleveland, OH, USA.|Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA.
authors: Shari D
authors: SD
authors: Bolen
authors: Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.|Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, MD, USA.
authors: Nisa M
authors: NM
authors: Maruthur
mesh_terms: D001943:Breast Neoplasms / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D012307:Risk Factors; D000097789:Glucagon-Like Peptide-1 Receptor Agonists
chemical_list: D007004:Hypoglycemic Agents; D000097789:Glucagon-Like Peptide-1 Receptor Agonists